GILUPI Nanomedizin - Product Pipeline Analysis, 2017 Update

Date: May 18, 2017
Pages: 29
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: E7D5137D8D7EN
Leaflet:

Download PDF Leaflet

GILUPI Nanomedizin - Product Pipeline Analysis, 2017 Update
Summary

GILUPI Nanomedizin (GILUPI) is a medical equipment company that commercializes and develops medical devices for isolating rare cells from blood for diagnosis. The company develops medical detector that is used in-vivo in a patient’s vein for catching rare cells such as tumor cells or fetal cells. Its products are used in the therapeutic areas of breast cancer, prostate cancer, diagnosing lung cancer, and prenatal diagnosis. GILUPI also has developed CellCollector for the in vivo isolation of circulating tumor cells. The company partners with various hospitals and medical universities. It also has operations in Cologne, Frankfurt, Munich, Berlin, Hamburg, and others. GILUPI is headquartered in Potsdam, Germany.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company GILUPI Nanomedizin
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
GILUPI Nanomedizin Company Overview
GILUPI Nanomedizin Company Snapshot
GILUPI Nanomedizin Pipeline Products and Ongoing Clinical Trials Overview
GILUPI Nanomedizin – Pipeline Analysis Overview
GILUPI Nanomedizin - Key Facts
GILUPI Nanomedizin - Major Products and Services
GILUPI Nanomedizin Pipeline Products by Development Stage
GILUPI Nanomedizin Ongoing Clinical Trials by Trial Status
GILUPI Nanomedizin Pipeline Products Overview
CellCollector Detektor CANCER01
CellCollector Detektor CANCER01 Product Overview
CellCollector Device - Cardiovascular Disease
CellCollector Device - Cardiovascular Disease Product Overview
CellCollector Device - Prostate Cancer
CellCollector Device - Prostate Cancer Product Overview
CellCollector Device - Sepsis
CellCollector Device - Sepsis Product Overview
CellCollector Device - Sepsis Clinical Trial
Diagnostic Test - Down's Syndrome
Diagnostic Test - Down's Syndrome Product Overview
Diagnostic Test - Prostate Cancer
Diagnostic Test - Prostate Cancer Product Overview
GILUPI Nanomedizin - Key Competitors
GILUPI Nanomedizin - Key Employees
GILUPI Nanomedizin - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
GILUPI Nanomedizin, Recent Developments
Oct 19, 2016: Enumeration and molecular characterization of circulating tumor cells in prostate cancer patients using the G tumor cells in prostate cancer patients using the GILUPI CellCollector
Aug 24, 2016: GILUPI Receives ISO 13485 Certification for Manufacturing and Distribution of Cell Separation Devices
Jul 27, 2016: GILUPI Strengthens Executive Team - Appoints Dr. Jens Pfannkuche as General Manager
May 13, 2016: Change In Management At GILUPI
May 29, 2014: EKF Molecular Diagnostics And Gilupi Announce Circulating Tumor Cell Dna Enrichment And Mutation Detection From Single Figures Of Cells
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

GILUPI Nanomedizin Pipeline Products and Ongoing Clinical Trials Overview
GILUPI Nanomedizin Pipeline Products by Equipment Type
GILUPI Nanomedizin Pipeline Products by Indication
GILUPI Nanomedizin Ongoing Clinical Trials by Trial Status
GILUPI Nanomedizin, Key Facts
GILUPI Nanomedizin, Major Products and Services
GILUPI Nanomedizin Number of Pipeline Products by Development Stage
GILUPI Nanomedizin Pipeline Products Summary by Development Stage
GILUPI Nanomedizin Ongoing Clinical Trials by Trial Status
GILUPI Nanomedizin Ongoing Clinical Trials Summary
CellCollector Detektor CANCER01 - Product Status
CellCollector Detektor CANCER01 - Product Description
CellCollector Device - Cardiovascular Disease - Product Status
CellCollector Device - Cardiovascular Disease - Product Description
CellCollector Device - Prostate Cancer - Product Status
CellCollector Device - Prostate Cancer - Product Description
CellCollector Device - Sepsis - Product Status
CellCollector Device - Sepsis - Product Description
CellCollector Device - Sepsis - Circulating Tumor Cells Spillage After Pulmonary Biopsy
Diagnostic Test - Down's Syndrome - Product Status
Diagnostic Test - Down's Syndrome - Product Description
Diagnostic Test - Prostate Cancer - Product Status
Diagnostic Test - Prostate Cancer - Product Description
GILUPI Nanomedizin, Key Employees
GILUPI Nanomedizin, Other Locations
Glossary

LIST OF FIGURES

GILUPI Nanomedizin Pipeline Products by Equipment Type
GILUPI Nanomedizin Pipeline Products by Development Stage
GILUPI Nanomedizin Ongoing Clinical Trials by Trial Status

COMPANIES MENTIONED

Sysmex Europe GmbH
Merzendorfer Reha-Technik GmbH
Hain Lifescience GmbH
Skip to top


Ask Your Question

GILUPI Nanomedizin - Product Pipeline Analysis, 2017 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: